BusinessHistogenics Corporation to Present at Upcoming Investor ConferencesBy Nasdaq OMXMar 28, 2018, 12:30 PM UTC
BusinessHistogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017By Nasdaq OMXMar 15, 2018, 10:00 AM UTC
BusinessHistogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual MeetingsBy Nasdaq OMXMar 2, 2018, 1:30 PM UTC
BusinessHistogenics Corporation to Present at Upcoming Investor ConferencesBy Nasdaq OMXFeb 20, 2018, 1:30 PM UTC
BusinessHistogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional SharesBy Nasdaq OMXJan 25, 2018, 9:05 PM UTC
BusinessHistogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese MarketBy Nasdaq OMXDec 21, 2017, 11:00 AM UTC
BusinessHistogenics Corporation Announces Third Quarter 2017 Financial and Operating ResultsBy Nasdaq OMXNov 9, 2017, 11:30 AM UTC
BusinessHistogenics Corporation Promotes Stephen Kennedy to Executive Vice President & Chief Operating OfficerBy Nasdaq OMXOct 12, 2017, 1:00 PM UTC
